SHARE
Low Dosage Hydrate Inhibitors Market

Low Dosage Hydrate Inhibitors Market Forecasts to 2028 – Global Analysis By Terrain Type (Offshore, Onshore), Product Type (Kinetic Hydrate Inhibitors (KHIs), Anti-agglomerate (AA) Inhibitors) and By Geography

4.5 (45 reviews)
Published: February 2022 ID: SMRC21342
4.5 (45 reviews)
Published: February 2022 ID: SMRC21342

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Low Dosage Hydrate Inhibitors Market is accounted for $70.85 million in 2021 and is expected to reach $138.94 million by 2028 growing at a CAGR of 10.1% during the forecast period. The low dosage hydrate inhibitor (LDHI) is an active hydrate inhibitor type, which is used in the prevention of hydrates gas formation at high pressure and lower temperature conditions. It is cost-effective and provides efficient control and oversees hydrates, which aid to maintain pipeline and flowline safe & secure from icy blockages. The LDHIs are mostly used in the offshore and onshore operations in the oil & gas industry.

Market Dynamics:

Driver:

Environmental footprint minimization


The reduction in logistical costs and environmental footprint minimization are expected to drive the market at a robust rate. Additionally, better operation under critical temperature conditions and low toxicity with increased compatibility of fluid systems with the help of low dosage hydrate inhibitors is estimated contribute significantly in the upsurge of demand for low dosage hydrate inhibitors during the forecast period. Moreover, increase in stability of the systems by reduction in depressurization in pipelines by the use of low dosage hydrate inhibitors during cold seasons is further anticipated to increase the requirement for low dosage hydrate inhibitors across the countries with predominant cold weathers as well as in developed and developing countries over the forecast period. The significant cost saving on account of low gas hydrate formation issues by the application of low dosage hydrate inhibitors is anticipated to create a steady upsurge in demand for low dosage hydrate inhibitors around the globe.

Restraint:

Availability of alternatives


The presence of cheaper alternatives in the market is predicted to behave as a major factor in hampering the growth of low dosage hydrate inhibitors market over the forecast period.

Opportunity:

Growing industrialization


The use of low dosage hydrate inhibitors allow for combination products generation which is predicted to expand the market of low dosage hydrate inhibitors over the forecast period. Growing industrialization along with increasing crude oil and gas consumption with manufacturers aiming for higher profit by lowering maintenance costs is expected to provide ample opportunities for the growth of the low dosage hydrate inhibitors market.

Threat:

Lack of awareness amongst the consumers


The lack of awareness amongst the consumers regarding the use and benefits of low dosage hydrate inhibitor reduces the consumption and raise the demand for substitute approaches such as high throughput experimentation (HTE) and thermodynamic inhibitors.

The anti-agglomerate (AA) inhibitors segment is expected to be the largest during the forecast period

Anti-agglomerate (AA) inhibitors provide superior performance in terms of maximum achievable sub-cooling, as compared to kinetic hydrate inhibitors (KHIs), as AA inhibitors do not have any limit to the maximum allowable shut-in time. These inhibitors are specially designed to keep hydrates dispersed in condensate or oil and thus the hydrates separate very slowly from the hydrocarbon liquid. Also, in the presence of a liquid hydrocarbon phase acting as the hydrate crystals carrier, these inhibitors deliver optimal performance, which is expected to boost sales. Growth of this segment is attributable to their high compatibility, relatively lower transportation costs, and reduced capital costs.

The offshore segment is expected to have the highest CAGR during the forecast period

Low dosage inhibitors can reduce the capital expenses in the offshore oil and gas industry by lowering the injection-rate and chemical-storage requirements. Further, these often eliminate the need for regeneration as the chemicals are not easily recoverable. This plays a significant role in offshore operations where desk space and payload are critical. They also help in boosting the production rates whenever the flow line or inhibitor-injection capacity is limited. The beneficial properties of low dosage hydrate inhibitors are anticipated to bolster their demand in the offshore terrain.

Region with largest share:

Asia Pacific is projected to hold the largest market share owing to the consistently growing demand for low dosage hydrate inhibitors from emerging markets such as China and India. China is expected to lead the overall low dosage hydrate inhibitors’ consumption, retaining the title of the largest producer and consumer of low dosage hydrate inhibitors, globally. The market growth in Asia Pacific can also be attributed to the increasing low dosage hydrate inhibitors application for extraction, refining and purification process of crude oil. Due to multiplying power production industries with rising energy demand in growing end-use industries, Asia Pacific is budding as a regional low dosage hydrate inhibitors and its derivatives consumption market.

Region with highest CAGR:

North America is projected to have the highest CAGR throughout the forecast period. The growth of North American market is primarily attributed to the region’s primacy in offshore gas production activities.

Key players in the market

Some of the key players profiled in the Low Dosage Hydrate Inhibitors Market include BASF SE, Yara International, Stella Maris LLC, Ashland, Halliburton, GasHydrate LLC, Evonik, Arkema Group, Ecolab, Clariant Chemicals, Baker Hughes Incorporated, Schlumberger, and ERO CHEM LLC.

Key developments:

In November 2019: Clariant developed a High Throughput Experimentation (HTE) platform for augmenting new product development. The platform combines intelligent analytics and automation to automate all aspects of development, such as synthesis, test planning, results analysis, formulation, and application testing. It was used to develop the first product in a line of next-generation AA-low dosage hydrate inhibitors.

In September 2016: Nalco Champion, an Ecolab Company expanded its low-dosage hydrate inhibitors portfolio in the Gulf of Mexico. This expansion will allow the customers to reduce safety risk, simplify logistics, and increase the production while reducing the total cost of operation and simplify logistics.

Terrain Types Covered:
• Offshore
• Onshore

Product Types Covered:
• Kinetic Hydrate Inhibitors (KHIs)
• Anti-agglomerate (AA) Inhibitors

End Users Covered:
• Gas Generation and Distribution Industries
• Oil Drill & Production Industries
• Oilfield Service Industries

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary      
        
2 Preface     
  
 2.1 Abstract       
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     

 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints      
 3.4 Opportunities     
 3.5 Threats      
 3.6 Product Analysis     
 3.7 End User Analysis     
 3.8 Emerging Markets     
 3.9 Impact of Covid-19     
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes     
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Low Dosage Hydrate Inhibitors Market, By Terrain Type  

 5.1 Introduction     
 5.2 Offshore      
 5.3 Onshore      
        
6 Global Low Dosage Hydrate Inhibitors Market, By Product Type 
 6.1 Introduction     
 6.2 Kinetic Hydrate Inhibitors (KHIs)    
  6.2.1 Co-Polymers    
  6.2.2 Polymers     
 6.3 Anti-agglomerate (AA) Inhibitors   
        
7 Global Low Dosage Hydrate Inhibitors Market, By End User  
 7.1 Introduction      
 7.2 Gas Generation and Distribution Industries   
 7.3 Oil Drill & Production Industries    
 7.4 Oilfield Service Industries    
        
8 Global Low Dosage Hydrate Inhibitors Market, By Geography  
 8.1 Introduction     
 8.2 North America      
  8.2.1 US     
  8.2.2 Canada     
  8.2.3 Mexico     
 8.3 Europe      
  8.3.1 Germany     
  8.3.2 UK     
  8.3.3 Italy     
  8.3.4 France     
  8.3.5 Spain     
  8.3.6 Rest of Europe    
 8.4 Asia Pacific     
  8.4.1 Japan     
  8.4.2 China     
  8.4.3 India     
  8.4.4 Australia     
  8.4.5 New Zealand    
  8.4.6 South Korea    
  8.4.7 Rest of Asia Pacific    
 8.5 South America     
  8.5.1 Argentina     
  8.5.2 Brazil     
  8.5.3 Chile     
  8.5.4 Rest of South America   
 8.6 Middle East & Africa     
  8.6.1 Saudi Arabia    
  8.6.2 UAE     
  8.6.3 Qatar     
  8.6.4 South Africa    
  8.6.5 Rest of Middle East & Africa   
        
9 Key Developments      
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 9.2 Acquisitions & Mergers    
 9.3 New Product Launch     
 9.4 Expansions     
 9.5 Other Key Strategies     
        
10 Company Profiling      
 10.1 BASF SE      
 10.2 Yara International     
 10.3 Stella Maris LLC      
 10.4 Ashland      
 10.5 Halliburton     
 10.6 GasHydrate LLC     
 10.7 Evonik      
 10.8 Arkema Group     
 10.9 Ecolab      
 10.10 Clariant Chemicals     
 10.11 Baker Hughes Incorporated    
 10.12 Schlumberger     
 10.13 ERO CHEM LLC     


List of Tables       
1 Global Low Dosage Hydrate Inhibitors Market Outlook, By Region (2020-2028) ($MN)
2 Global Low Dosage Hydrate Inhibitors Market Outlook, By Terrain Type (2020-2028) ($MN)
3 Global Low Dosage Hydrate Inhibitors Market Outlook, By Offshore (2020-2028) ($MN)
4 Global Low Dosage Hydrate Inhibitors Market Outlook, By Onshore (2020-2028) ($MN)
5 Global Low Dosage Hydrate Inhibitors Market Outlook, By Product Type (2020-2028) ($MN)
6 Global Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHIs) (2020-2028) ($MN)
7 Global Low Dosage Hydrate Inhibitors Market Outlook, By Co-Polymers (2020-2028) ($MN)
8 Global Low Dosage Hydrate Inhibitors Market Outlook, By Polymers (2020-2028) ($MN)
9 Global Low Dosage Hydrate Inhibitors Market Outlook, By Anti-agglomerate (AA) Inhibitors (2020-2028) ($MN)
10 Global Low Dosage Hydrate Inhibitors Market Outlook, By End User (2020-2028) ($MN)
11 Global Low Dosage Hydrate Inhibitors Market Outlook, By Gas Generation and Distribution Industries (2020-2028) ($MN)
12 Global Low Dosage Hydrate Inhibitors Market Outlook, By Oil Drill & Production Industries (2020-2028) ($MN)
13 Global Low Dosage Hydrate Inhibitors Market Outlook, By Oilfield Service Industries (2020-2028) ($MN)
14 North America Low Dosage Hydrate Inhibitors Market Outlook, By Country (2020-2028) ($MN)
15 North America Low Dosage Hydrate Inhibitors Market Outlook, By Terrain Type (2020-2028) ($MN)
16 North America Low Dosage Hydrate Inhibitors Market Outlook, By Offshore (2020-2028) ($MN)
17 North America Low Dosage Hydrate Inhibitors Market Outlook, By Onshore (2020-2028) ($MN)
18 North America Low Dosage Hydrate Inhibitors Market Outlook, By Product Type (2020-2028) ($MN)
19 North America Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHIs) (2020-2028) ($MN)
20 North America Low Dosage Hydrate Inhibitors Market Outlook, By Co-Polymers (2020-2028) ($MN)
21 North America Low Dosage Hydrate Inhibitors Market Outlook, By Polymers (2020-2028) ($MN)
22 North America Low Dosage Hydrate Inhibitors Market Outlook, By Anti-agglomerate (AA) Inhibitors (2020-2028) ($MN)
23 North America Low Dosage Hydrate Inhibitors Market Outlook, By End User (2020-2028) ($MN)
24 North America Low Dosage Hydrate Inhibitors Market Outlook, By Gas Generation and Distribution Industries (2020-2028) ($MN)
25 North America Low Dosage Hydrate Inhibitors Market Outlook, By Oil Drill & Production Industries (2020-2028) ($MN)
26 North America Low Dosage Hydrate Inhibitors Market Outlook, By Oilfield Service Industries (2020-2028) ($MN)
27 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Country (2020-2028) ($MN)
28 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Terrain Type (2020-2028) ($MN)
29 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Offshore (2020-2028) ($MN)
30 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Onshore (2020-2028) ($MN)
31 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Product Type (2020-2028) ($MN)
32 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHIs) (2020-2028) ($MN)
33 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Co-Polymers (2020-2028) ($MN)
34 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Polymers (2020-2028) ($MN)
35 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Anti-agglomerate (AA) Inhibitors (2020-2028) ($MN)
36 Europe Low Dosage Hydrate Inhibitors Market Outlook, By End User (2020-2028) ($MN)
37 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Gas Generation and Distribution Industries (2020-2028) ($MN)
38 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Oil Drill & Production Industries (2020-2028) ($MN)
39 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Oilfield Service Industries (2020-2028) ($MN)
40 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Country (2020-2028) ($MN)
41 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Terrain Type (2020-2028) ($MN)
42 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Offshore (2020-2028) ($MN)
43 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Onshore (2020-2028) ($MN)
44 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Product Type (2020-2028) ($MN)
45 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHIs) (2020-2028) ($MN)
46 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Co-Polymers (2020-2028) ($MN)
47 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Polymers (2020-2028) ($MN)
48 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Anti-agglomerate (AA) Inhibitors (2020-2028) ($MN)
49 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By End User (2020-2028) ($MN)
50 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Gas Generation and Distribution Industries (2020-2028) ($MN)
51 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Oil Drill & Production Industries (2020-2028) ($MN)
52 Asia Pacific Low Dosage Hydrate Inhibitors Market Outlook, By Oilfield Service Industries (2020-2028) ($MN)
53 South America Low Dosage Hydrate Inhibitors Market Outlook, By Country (2020-2028) ($MN)
54 South America Low Dosage Hydrate Inhibitors Market Outlook, By Terrain Type (2020-2028) ($MN)
55 South America Low Dosage Hydrate Inhibitors Market Outlook, By Offshore (2020-2028) ($MN)
56 South America Low Dosage Hydrate Inhibitors Market Outlook, By Onshore (2020-2028) ($MN)
57 South America Low Dosage Hydrate Inhibitors Market Outlook, By Product Type (2020-2028) ($MN)
58 South America Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHIs) (2020-2028) ($MN)
59 South America Low Dosage Hydrate Inhibitors Market Outlook, By Co-Polymers (2020-2028) ($MN)
60 South America Low Dosage Hydrate Inhibitors Market Outlook, By Polymers (2020-2028) ($MN)
61 South America Low Dosage Hydrate Inhibitors Market Outlook, By Anti-agglomerate (AA) Inhibitors (2020-2028) ($MN)
62 South America Low Dosage Hydrate Inhibitors Market Outlook, By End User (2020-2028) ($MN)
63 South America Low Dosage Hydrate Inhibitors Market Outlook, By Gas Generation and Distribution Industries (2020-2028) ($MN)
64 South America Low Dosage Hydrate Inhibitors Market Outlook, By Oil Drill & Production Industries (2020-2028) ($MN)
65 South America Low Dosage Hydrate Inhibitors Market Outlook, By Oilfield Service Industries (2020-2028) ($MN)
66 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Country (2020-2028) ($MN)
67 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Terrain Type (2020-2028) ($MN)
68 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Offshore (2020-2028) ($MN)
69 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Onshore (2020-2028) ($MN)
70 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Product Type (2020-2028) ($MN)
71 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHIs) (2020-2028) ($MN)
72 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Co-Polymers (2020-2028) ($MN)
73 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Polymers (2020-2028) ($MN)
74 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Anti-agglomerate (AA) Inhibitors (2020-2028) ($MN)
75 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By End User (2020-2028) ($MN)
76 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Gas Generation and Distribution Industries (2020-2028) ($MN)
77 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Oil Drill & Production Industries (2020-2028) ($MN)
78 Middle East & Africa Low Dosage Hydrate Inhibitors Market Outlook, By Oilfield Service Industries (2020-2028) ($MN)

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials